HIGHLIGHTS
- who: Annika Ru00e4hni from the Llc, Tallinn, Estonia, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia. , dxlabs Llc, Tallinn, Estonia. have published the article: Melanoma-specific antigen-associated antitumor antibody reactivity as an immune-related biomarker for targeted immunotherapies, in the Journal: (JOURNAL) of 20/07/2021
- what: This study provides insights into the differences and similarities in tumorspecific immunogenicity related to targeted immune treatments. This study characterized the antibodies produced following treatment with two different types of immunotherapies that treat skin cancer to gain insights into how the immune system responds . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.